The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia

European Journal of Cancer

Volumn 48, Issue 12, 2012, Pages 1884-1895

  Zhao, Zhi Gang ^a   Xu, Wen ^a   Sun, Li ^b   Li, Wei Ming ^b   Li, Qiu Bai ^b   Zou, Ping ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CD4+CD25+Foxp3+Tregs; Chronic myeloid leukaemia; Dendritic cells; Immunoregulatory; Mesenchymal stem cells

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; MALE; MESENCHYMAL STEM CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE;

ADULT; BONE MARROW; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOMODULATION; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84864151392     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.11.003     Document Type: Article

References (40)

1. Y. Jiang, B.N. Jahagirdar, and R.L. Reinhardt Pluripotency of mesenchymal stem cell derived from adult marrow Nature 418 2002 41 49
2. A. Bartholomew, C. Sturgeon, and M. Siatskas Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp Hematol 30 2002 42 48
3. K. Le Blanc, F. Frassoni, and L. Ball Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Lancet 371 2008 1579 1586
4. E.M. Horwitz, D.J. Prockop, and L.A. Fitzpatrick Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta Nat Med 5 1999 309 313
5. O.N. Koc, S.L. Gerson, and B.W. Cooper Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy J Clin Oncol 18 2000 307 316
6. L.M. Ball, M.E. Bernardo, and H. Roelofs Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation Blood 110 2007 2764 2767
7. H.M. Lazarus, S.E. Haynesworth, S.L. Gerson, N.S. Rosenthal, and A.I. Caplan Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use Bone Marrow Transplant 16 1995 557 564
8. F. Baron, C. Lechanteur, and E. Willems Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning Biol Blood Marrow Transplant 16 2010 838 847
9. F. Chapuis, M. Rosenzwajg, and M. Yagello Differentiation of human dendritic cells from monocytes in vitro Eur J Immunol 27 1997 431 441
10. I. Mellman, and R.M. Steinman Dendritic cells: specialized and regulated antigen processing machines Cell 106 2001 255 258
11. J. Banchereau, F. Briere, and C. Caux Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767 811
12. Z.G. Zhao, X.Q. Tang, and Y. You Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia Leukemia Res 30 2006 993 1003
13. Z.G. Zhao, W.M. Li, Z.C. Chen, and P. Zou Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia Immunol Invest 37 2008 726 739
14. B. Zhang, R. Liu, and D. Shi Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population Blood 113 2009 46 57
15. R.H. Schwartz T cell anergy Annu Rev Immunol 21 2003 305 334
16. M. Krampera, S. Glennie, and J. Dyson Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide Blood 101 2003 3722 3729
17. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
18. D. Santoli, P.D. Phillips, T.L. Colt, and R.B. Zurier Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids J Clin Invest 85 1990 424 432
19. D.H. Munn, M.D. Sharma, and J.R. Lee Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 297 2002 1867 1870
20. R. Meisel, A. Zibert, and M. Laryea Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 2004 4619 4621
21. K. Sato, K. Ozaki, and I. Oh Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells Blood 109 2007 228 234
22. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 2005 345 352
23. K. Sato, N. Yamashita, N. Yamashita, M. Baba, and T. Matsuyama Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse Immunity 18 2003 367 379
24. K. Sato, N. Yamashita, M. Baba, and T. Matsuyama Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells Blood 101 2003 3581 3589
25. Y. Peng, Y. Laouar, M.O. Li, E.A. Green, and R.A. Flavell TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes Proc Natl Acad Sci USA 101 2004 4572 4577
26. W. Chen, W. Jin, and N. Hardegen Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 J Exp Med 198 2003 1875 1886
27. S. Yamazaki, A.J. Bonito, and R. Spisek Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+CD4+ regulatory T cells from peripheral Foxp3 precursors Blood 110 2007 4293 4302
28. H. Tang, Z.H. Guo, and M.H. Zhang Endothelial stroma programs hematopoietic stem cells to differentiate into regulatory dendritic cells through IL-10 Blood 108 2006 1189 1197
29. R.M. Steinman, and M.C. Nussenzweig Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance Proc Natl Acad Sci USA 99 2002 351 358
30. C.T. Weaver, L.E. Harrington, P.R. Mangan, M. Gavrieli, and K.M. Murphy Th17: an effector CD4 T cell lineage with regulatory T cell ties Immunity 24 2006 677 688
31. A.E. Morelli, and A.W. Thomson Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction Immunol Rev 196 2003 125 146
32. L. Gorelik, and R.A. Flavell Transforming growth factor-beta in T-cell biology Nat Rev Immunol 2 2002 46 53
33. W. Chen, and S.M. Wahl TGF-beta: receptors, signaling pathways and autoimmunity Curr Dir Autoimmun 5 2002 62 91
34. S.A. Patel, J.R. Meyer, and S.J. Greco Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta J Immunol 184 2010 5885 5894
35. S. Beyth, Z. Borovsky, and D. Mevorach Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Blood 105 2005 2214 2219
36. K. Le Blanc, L. Tammik, B. Sundberg, S.E. Haynesworth, and O. Ringdén Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scand J Immunol 57 2003 11 20
37. F. Gieseke, J. Böhringer, and R. Bussolari Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells Blood 116 2010 3770 3779
38. H. Lazarus, P. Curtin, and S. Devine Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients Biol Blood Marrow Transplant 11 2005 389 398
39. J.Y. Weng, X. Du, and S.X. Geng Mesenchymal stem cell as salvage treatment for refractory chronic GVHD Bone Marrow Transplant 45 2010 1732 1740
40. K. Le Blanc, I. Rasmusson, and B. Sundberg Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 2004 1439 1441